DuPont de Nemours, Inc. $DD Position Boosted by TI Trust Inc.

TI Trust Inc. lifted its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 429.8% in the third quarter, HoldingsChannel.com reports. The firm owned 14,841 shares of the basic materials company’s stock after acquiring an additional 12,040 shares during the quarter. DuPont de Nemours accounts for about 1.0% of TI Trust Inc.’s investment portfolio, making the stock its 29th largest holding. TI Trust Inc.’s holdings in DuPont de Nemours were worth $1,928,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DD. Crossmark Global Holdings Inc. purchased a new position in DuPont de Nemours during the third quarter worth about $18,221,000. Quadrant Capital Group LLC increased its position in shares of DuPont de Nemours by 230.6% during the third quarter. Quadrant Capital Group LLC now owns 12,791 shares of the basic materials company’s stock valued at $1,661,000 after acquiring an additional 8,922 shares during the last quarter. Physician Wealth Advisors Inc. increased its position in shares of DuPont de Nemours by 223.1% during the third quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock valued at $27,000 after acquiring an additional 145 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of DuPont de Nemours by 257.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 172,776 shares of the basic materials company’s stock valued at $22,442,000 after acquiring an additional 124,492 shares during the period. Finally, Integrated Advisors Network LLC raised its stake in shares of DuPont de Nemours by 241.9% in the 3rd quarter. Integrated Advisors Network LLC now owns 6,502 shares of the basic materials company’s stock valued at $845,000 after acquiring an additional 4,600 shares during the period. 73.96% of the stock is owned by institutional investors and hedge funds.

DuPont de Nemours Price Performance

DD opened at $134.11 on Thursday. The stock’s 50-day moving average price is $132.62 and its 200 day moving average price is $138.13. DuPont de Nemours, Inc. has a 12-month low of $99.20 and a 12-month high of $157.98. The firm has a market cap of $18.11 billion, a price-to-earnings ratio of 298.08, a PEG ratio of 1.23 and a beta of 1.05. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23.

DuPont de Nemours (NYSE:DD – Get Free Report) last released its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.76 by $0.12. The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.81 billion. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%. DuPont de Nemours’s revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.12 EPS. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, sell-side analysts expect that DuPont de Nemours, Inc. will post 7.25 earnings per share for the current year.

DuPont de Nemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, November 30th. DuPont de Nemours’s dividend payout ratio is currently 533.33%.

Wall Street Analyst Weigh In

DD has been the topic of several recent analyst reports. The Goldman Sachs Group decreased their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a report on Wednesday, September 30th. Citigroup lowered their price objective on shares of DuPont de Nemours from $170.00 to $162.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. Barclays initiated coverage on shares of DuPont de Nemours in a report on Tuesday, October 13th. They issued an “overweight” rating and a $156.00 target price for the company. JPMorgan Chase & Co. lowered DuPont de Nemours from an “overweight” rating to a “neutral” rating and cut their target price for the company from $172.00 to $145.00 in a research report on Friday, October 9th. Finally, UBS Group cut their target price on DuPont de Nemours from $178.00 to $172.00 and set a “buy” rating on the stock in a research report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $162.00.

Check Out Our Latest Stock Analysis on DuPont de Nemours

DuPont de Nemours Company Profile

(Free Report)

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

Featured Stories

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.